Glenn Morinishi in Anaheim, California

Home California Anaheim

Glenn Morinishi has Family Practice as his primary medical specialty. Their primary office is: 710 N Euclid St in Anaheim, California.

They're a part of the: Primary And Multi-specialty Clinics Of Anaheim medical group which has around 14 members. You can call their office at 714-517-2000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Southern California Keck School Of Medicine and graduated in 1987 (around 37 years of experience). They are listed as doing telehealth appointments.

Glenn K Morinishi Office Phone and Directions

Glenn Morinishi
Primary And Multi-specialty Clinics Of Anaheim
710 N Euclid St
Anaheim, California 92801
714-517-2000

Patient Ratings
Please rate your experience with Glenn Morinishi below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 714-517-2000

Enter a starting address:

Healthcare Info for Glenn Morinishi

Medical School: University Of Southern California Keck School Of Medicine
Graduation Year: 1987
The Primary Medical Specialty for Glenn Morinishi is listed as: Family Practice
Approximate Years of Experience: 37
PAC (PECOS ID)#: 3173781507
NPI #: 1871648121
NPI Created On: 01/25/2007
NPI Last Updated Listed as: 06/24/2019
Primary Taxonomy Code: 207Q00000X
License Number:
G65039
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 850253441

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Gastroenterology

Name of Drug #1: XIFAXAN

Open Associated Drug #1: 65649-303-02